{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:47:26Z","timestamp":1794732446737,"version":"4.9.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD), including classical diabetic nephropathy, is a leading cause of chronic kidney disease and kidney replacement therapy. Vitamin D supplementation has been proposed to reduce albuminuria, but the available reviews are heterogeneous and redundant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To critically evaluate and summarize the efficacy and safety of native vitamin D and active vitamin D analogs in adults with DKD, including studies reported as diabetic nephropathy (DN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An overview of reviews registered in PROSPERO (CRD420251250914). Systematic reviews, with or without meta-analysis, were searched in MEDLINE\/PubMed, Embase, the Cochrane Library, Web of Science, and Scopus, without language restrictions, through April 2, 2026. Methodological quality was assessed with AMSTAR-2, risk of bias with ROBIS, overlap with Corrected Covered Area (CCA), and certainty of evidence with GRADE. The synthesis used one anchor review per outcome, without\n                      <jats:italic>de novo<\/jats:italic>\n                      quantitative reanalysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven reviews met the eligibility criteria; nine provided evidence derived from randomized trials or separable randomized-trial data, and two were retained as contextual evidence. GRADE certainty was low for the surrogate urinary outcomes UACR and UAER, low to very low for 24-hour proteinuria, and very low or not evaluable for renal function, kidney replacement therapy, mortality, cardiovascular events, safety, and metabolic-inflammatory outcomes. Overlap was high (overall CCA, 13.5%; RCT-derived corpus, 14.1%). The evidence was compatible with low-certainty reductions in surrogate urinary outcomes, especially UACR and UAER, without consistent benefit for eGFR, serum creatinine, kidney replacement therapy, mortality, or cardiovascular events; safety was insufficiently reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vitamin D shows a low-certainty reduction in surrogate urinary markers of albuminuria\/proteinuria in DKD, but current evidence is insufficient to support vitamin D as a specific renoprotective intervention beyond conventional indications for deficiency or mineral and bone disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251250914<\/jats:ext-link>\n                      , identifier CRD420251250914.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1883351","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:21:53Z","timestamp":1784089313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of vitamin D supplementation in diabetic kidney disease: an umbrella review of systematic reviews and meta-analyses"],"prefix":"10.3389","volume":"6","author":[{"given":"V\u00edctor Juan","family":"Vera-Ponce","sequence":"first","affiliation":[{"name":"Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodr\u00edguez de Mendoza de Amazonas (UNTRM)","place":["Chachapoyas, Amazonas, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhosmer","family":"Ballena-Caicedo","sequence":"additional","affiliation":[{"name":"Facultad de Medicina (FAMED), Universidad Nacional Toribio Rodr\u00edguez de Mendoza de Amazonas (UNTRM)","place":["Chachapoyas, Amazonas, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"B2","volume-title":"Idf Diabetes Atlas","year":"2025"},{"key":"B3","article-title":"Diabetes data in South and Central America","volume-title":"IDF Diabetes Atlas 2025.","year":"2025"},{"key":"B4","article-title":"Peru country profile","volume-title":"IDF South and Central America Region","year":"2025"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1531811","article-title":"Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the Global Burden of Disease Study 2021","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043751","article-title":"Vitamin D and diabetic kidney disease","volume":"24","author":"Huang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.kint.2023.07.010","article-title":"Vitamin D supplementation in people with chronic kidney disease","volume":"104","author":"Vervloet","year":"2023","journal-title":"Kidney Int"},{"key":"B8","article-title":"Effect of vitamin D on urinary albumin excretion in diabetic nephropathy patients: a meta-analysis of randomized controlled trials","volume":"16","author":"He","year":"2022","journal-title":"Iran J Kidney Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231212039","article-title":"Are there any pleiotropic benefits of vitamin D in patients with diabetic kidney disease? A systematic review of randomized controlled trials","volume":"10","author":"Sharma","year":"2023","journal-title":"Can J Kidney Health Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13410-022-01108-w","article-title":"A systematic review and meta-analysis of randomized control trials of vitamin D supplementation in diabetic nephropathy","volume":"43","author":"Xuan","year":"2023","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/20420188251319476","article-title":"Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses","volume":"16","author":"Chackochan","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: A new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2018.12.005","article-title":"Role of vitamin D and its analogues in diabetic nephropathy: a meta-analysis","volume":"357","author":"Gupta","year":"2019","journal-title":"Am J Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2023.05.006","article-title":"Effects of vitamin D supplementation in diabetic kidney disease: a systematic review","volume":"33","author":"de Oliveira E Silva Ullmann","year":"2023","journal-title":"J Ren Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000498838","article-title":"Effects of vitamin D supplementation on renal function, inflammation and glycemic control in patients with diabetic nephropathy: a systematic review and meta-analysis","volume":"44","author":"Wang","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0350-0","article-title":"Efficacy and safety of vitamin D3 in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"127","author":"Zhao","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.09.009","article-title":"Use of paricalcitol as adjunctive therapy to renin-angiotensin-aldosterone system inhibition for diabetic nephropathy: a systematic review of the literature","volume":"41","author":"Schuster","year":"2019","journal-title":"Clin Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2015.04.009","article-title":"Vitamin D and diabetic nephropathy: a systematic review and meta-analysis","volume":"31","author":"Derakhshanian","year":"2015","journal-title":"Nutrition"},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40200-015-0186-6","article-title":"Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review","volume":"14","author":"Chokhandre","year":"2015","journal-title":"J Diabetes Metab Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2021.763844","article-title":"Vitamin D analogs can retard the onset or progression of diabetic kidney disease: a systematic review","volume":"2","author":"Uwaezuoke","year":"2021","journal-title":"Front Clin Diabetes Healthc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1883351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:21:54Z","timestamp":1784089314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1883351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":27,"alternative-id":["10.3389\/fneph.2026.1883351"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1883351","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fneph.2026.1883351.s001","asserted-by":"subject"}]},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1883351"}}